A subgroup analysis found that pembrolizumab plus chemotherapy improved disease-free survival in high-risk patients with ...

This is important because the traditional teaching that nulliparity is a greater risk factor for endometrial cancer is tied to this cell type, which accounts for 80% to 85% of uterine cancers.

827 patients with advanced endometrial cancer who had progressive disease after platinum-based chemotherapy were randomly assigned to receive lenvatinib plus pembrolizumab (411 patients ...

So, and it is nice to speak about gynecologic cancers, as we know, endometrial cancer was and still is the most common ... second line was Vicki Makker and her colleagues put pembrolizumab and ...

Merck's Keytruda (pembrolizumab ... as in a combination regimen alongside Eisai's Lenvima (lenvatinib) in previously treated endometrial cancer without dMMR mutations. Approval in first-line ...

Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published online Oct. 16 ...

ImmunityBio has announced the launch of the Phase I/II QUILT 502 clinical trial of ANKTIVA (nogapendekin alfa inbakicept-pmln), plus the investigational AdHER2DC vaccine, as a potential therapy ...

The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...

Surgery is the cornerstone of treatment for uterine (endometrial) cancer at Memorial Sloan Kettering. For many women, it’s used for removing the cancer as well as diagnosis and staging information.

The group has published its findings in prominent journals. You may wonder how to know if you have uterine cancer. This condition is one of the most common forms of cancer, and most often ...

Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published online Oct. 16 in ...

Findings seen in combination with chemotherapy following surgery in patients with curative intent. HealthDay News — Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in ...